American Electric Power Company Inc vs ARK Genomic Revolution ETF — how do they compare? American Electric Power Company Inc trades at $123.54 (market cap $67.28B), while ARK Genomic Revolution ETF trades at $44.43. The key difference: American Electric Power Company Inc pays a 3.07% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, American Electric Power Company Inc nearer its low. Which is the better fit depends on your goals.
| AEP | ARKG | |
|---|---|---|
Market Cap | $67.28B | — |
Sector | Utilities | Sector/Thematic |
52-Week High | $138.69 | $44.55 |
52-Week Low | $106.44 | $24.02 |
Enterprise Value | $120.17B | — |
Dividend Yield | 3.07% | — |
Signals from Pluang's Aura AI — not financial advice
AEP trades at $122.84, down 2.3% on the day, with a bearish technical signal. Recent Q2 2026 earnings missed estimates at $1.36 per share versus $1.48 expected, though revenue grew 7% year-over-year. The company raised full-year 2026 operating EPS guidance to $6.25–$6.55, supported by 69 GW of contracted load and a $78 billion capital plan. Analyst consensus remains strongly bullish with a $140.89 price target and no sell ratings.
The outlook is positive due to robust demand from data centers and infrastructure growth, but risks include high capital expenditures and interest expenses. Valuation metrics like a P/E of 21.42 are elevated, requiring sustained earnings growth to justify. The stock offers a stable dividend, with the next payment of $0.95 ex-dividend on August 10, 2026.
No Aura AI signal available yet.
Trailing returns across standard periods
American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
Read more on AEP →ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →